The long-term weight-loss agents approved by the FDA of the United States are orlistat, lorcaserin, naltrexone-bupropion, topiramate phenylacetate, LIR, SMG etc
In the meantime, however, experts warn against using GLP-1 medications this way, even in microdoses
The 20242025 CMS rules tightening marketing and requiring equitable prior authorization practices are steps indicating that strong oversight is needed to protect beneficiaries interests
doi: 10.1016/j.postharvbio.2015.02.015 23 HornbacherJ.RumlowA.PallmannP.TurciosA
doi: 10.1111/j.1365-2826.2008.01814.x 80 RichardCDTolleVLowMJ
That said, it is not FDA-approved, so it should only be considered under licensed medical supervision